Johan Kördel

Board Member

Johan Kördel joined Lundbeckfonden Ventures in 2010 as a senior partner. He is a director of Acacia Pharma, Amplyx Pharmaceuticals, Enterome, Iconic Therapeutics, SARomics and VHSquared. Previously, he was a board member of Syntaxin (sold to Ipsen), Celladon, Ziarco (sold to Novartis), River Vision (sold to Horizon), Bonesupport, EQL Pharma and ...

Roles at Reneo Pharmaceuticals

  • Board Member

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.